158 related articles for article (PubMed ID: 23689387)
1. Heparin for venous thromboembolism prophylaxis in patients with acute spinal cord injury: a systematic review and meta-analysis.
Chen HL; Wang XD
Spinal Cord; 2013 Aug; 51(8):596-602. PubMed ID: 23689387
[TBL] [Abstract][Full Text] [Related]
2. Meta-analysis of heparin therapy for preventing venous thromboembolism in acute spinal cord injury.
Liu Y; Xu H; Liu F; Lv Z; Kan S; Ning G; Feng S
Int J Surg; 2017 Jul; 43():94-100. PubMed ID: 28579397
[TBL] [Abstract][Full Text] [Related]
3. Enoxaparin versus tinzaparin for venous thromboembolic prophylaxis during rehabilitation after acute spinal cord injury: a retrospective cohort study comparing safety and efficacy.
Marciniak CM; Kaplan J; Welty L; Chen D
PM R; 2012 Jan; 4(1):11-7. PubMed ID: 22269449
[TBL] [Abstract][Full Text] [Related]
4. Dalteparin vs low-dose unfractionated heparin for prophylaxis against clinically evident venous thromboembolism in acute traumatic spinal cord injury: a retrospective cohort study.
Worley S; Short C; Pike J; Anderson D; Douglas JA; Thompson K
J Spinal Cord Med; 2008; 31(4):379-87. PubMed ID: 18959355
[TBL] [Abstract][Full Text] [Related]
5. Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer.
Akl EA; Kahale L; Neumann I; Barba M; Sperati F; Terrenato I; Muti P; Schünemann H
Cochrane Database Syst Rev; 2014 Jun; (6):CD006649. PubMed ID: 24945634
[TBL] [Abstract][Full Text] [Related]
6. Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer.
Akl EA; Vasireddi SR; Gunukula S; Barba M; Sperati F; Terrenato I; Muti P; Schünemann H
Cochrane Database Syst Rev; 2011 Feb; (2):CD006649. PubMed ID: 21328285
[TBL] [Abstract][Full Text] [Related]
7. Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer.
Akl EA; Vasireddi SR; Gunukula S; Barba M; Sperati F; Terrenato I; Muti P; Schünemann H
Cochrane Database Syst Rev; 2011 Jun; (6):CD006649. PubMed ID: 21678360
[TBL] [Abstract][Full Text] [Related]
8. Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer.
Akl EA; Vasireddi SR; Gunukula S; Barba M; Sperati F; Terrenato I; Muti P; Schünemann H
Cochrane Database Syst Rev; 2011 Apr; (4):CD006649. PubMed ID: 21491395
[TBL] [Abstract][Full Text] [Related]
9. Low-Molecular-Weight Heparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Arthroscopic Surgery and Anterior Cruciate Ligament Reconstruction: A Meta-analysis of Randomized Controlled Trials.
Zhu J; Jiang H; Marshall B; Li J; Tang X
Am J Sports Med; 2019 Jul; 47(8):1994-2002. PubMed ID: 30113231
[TBL] [Abstract][Full Text] [Related]
10. Venous thromboembolism prophylaxis in patients undergoing cranial neurosurgery: a systematic review and meta-analysis.
Hamilton MG; Yee WH; Hull RD; Ghali WA
Neurosurgery; 2011 Mar; 68(3):571-81. PubMed ID: 21311292
[TBL] [Abstract][Full Text] [Related]
11. Low molecular weight heparin (LMWH) for primary thrombo-prophylaxis in patients with solid malignancies - systematic review and meta-analysis.
Ben-Aharon I; Stemmer SM; Leibovici L; Shpilberg O; Sulkes A; Gafter-Gvili A
Acta Oncol; 2014 Sep; 53(9):1230-7. PubMed ID: 25162954
[TBL] [Abstract][Full Text] [Related]
12. Prevention of venous thromboembolic events with low-molecular-weight heparin in the non-major orthopaedic setting: meta-analysis of randomized controlled trials.
Chapelle C; Rosencher N; Jacques Zufferey P; Mismetti P; Cucherat M; Laporte S;
Arthroscopy; 2014 Aug; 30(8):987-96. PubMed ID: 24813323
[TBL] [Abstract][Full Text] [Related]
13. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.
Kanaan AO; Silva MA; Donovan JL; Roy T; Al-Homsi AS
Clin Ther; 2007 Nov; 29(11):2395-405. PubMed ID: 18158080
[TBL] [Abstract][Full Text] [Related]
14. A Review of Two Heparin Prophylaxes for Trauma.
Yu HD
J Trauma Nurs; 2019; 26(5):263-269. PubMed ID: 31503200
[TBL] [Abstract][Full Text] [Related]
15. Safety and comparative efficacy of initiating low-molecular-weight heparin within 24 hours of injury or surgery for venous thromboembolism prophylaxis in patients with spinal cord injury: a prospective TRACK-SCI registry study.
Lui A; Park C; Chryssikos T; Radabaugh H; Patel A; Aabedi AA; Ferguson AR; Torres Espin A; Mummaneni PV; Dhall SS; Duong-Fernandez X; Saigal R; Chou A; Pan J; Singh V; Hemmerle DD; Kyritsis N; Talbott JF; Pascual LU; Huie JR; Whetstone WD; Bresnahan JC; Beattie MS; Weinstein PR; Manley GT; DiGiorgio AM
Neurosurg Focus; 2023 Oct; 55(4):E17. PubMed ID: 37778033
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis on anticoagulation and prevention of thrombosis and mortality among patients with lung cancer.
Fuentes HE; Oramas DM; Paz LH; Casanegra AI; Mansfield AS; Tafur AJ
Thromb Res; 2017 Jun; 154():28-34. PubMed ID: 28402864
[TBL] [Abstract][Full Text] [Related]
17. Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer.
Akl EA; Kahale L; Sperati F; Neumann I; Labedi N; Terrenato I; Barba M; Sempos EV; Muti P; Cook D; Schünemann H
Cochrane Database Syst Rev; 2014 Jun; (6):CD009447. PubMed ID: 24966161
[TBL] [Abstract][Full Text] [Related]
18. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Geerts WH; Pineo GF; Heit JA; Bergqvist D; Lassen MR; Colwell CW; Ray JG
Chest; 2004 Sep; 126(3 Suppl):338S-400S. PubMed ID: 15383478
[TBL] [Abstract][Full Text] [Related]
19. The effectiveness and safety of LMWH for preventing thrombosis in patients with spinal cord injury: a meta-analysis.
Lin Z; Sun Y; Xue H; Chen L; Yan C; Panayi AC; Mi B; Liu G
J Orthop Surg Res; 2021 Apr; 16(1):262. PubMed ID: 33853656
[TBL] [Abstract][Full Text] [Related]
20. Low molecular weight heparin in treating patients with lung cancer received chemotherapy: A meta-analysis.
Liu ZL; Wang Q; Wang M; Wang B; Huang LN
J Cancer Res Ther; 2018 Jun; 14(Supplement):S437-S443. PubMed ID: 29970703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]